{"id":112632,"date":"2023-10-26T11:18:22","date_gmt":"2023-10-26T05:48:22","guid":{"rendered":"https:\/\/tradebrains.in\/features\/?p=112632"},"modified":"2023-10-26T12:05:23","modified_gmt":"2023-10-26T06:35:23","slug":"pharma-stock-jumps-up-to-7-after-it-receives-approval-for-its-drug-in-united-kingdom","status":"publish","type":"post","link":"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-up-to-7-after-it-receives-approval-for-its-drug-in-united-kingdom\/","title":{"rendered":"Pharma stock jumps up to 7% after it receives approval for its drug in United Kingdom\u00a0"},"content":{"rendered":"<div class=\"trade-content_2\" style=\"margin-left: auto;margin-right: auto;text-align: center;\" id=\"trade-1292152525\"><p><a href=\"https:\/\/tradebrains.in\/get\/telegram\/\"><img decoding=\"async\" class=\"alignnone wp-image-101992\" src=\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/01\/telegram-channel-300x119.png\" alt=\"\" width=\"148\" height=\"59\" \/><\/a> <a href=\"https:\/\/news.google.com\/publications\/CAAqBwgKMN3Epgswxc--Aw?hl=en-IN&amp;gl=IN&amp;ceid=IN%3Aen\"><img decoding=\"async\" class=\"alignnone wp-image-123430\" src=\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2024\/05\/follow-on-google-news-300x82.png\" alt=\"follow-on-google-news\" width=\"222\" height=\"61\" srcset=\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2024\/05\/follow-on-google-news-300x82.png 300w, https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2024\/05\/follow-on-google-news-150x41.png 150w, https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2024\/05\/follow-on-google-news.png 468w\" sizes=\"(max-width: 222px) 100vw, 222px\" \/><\/a><\/p>\n<\/div><p>Shares of one of the leading fixed dosage injectable manufacturers around the world gained 7 percent in the day\u2019s trade after it received authorization for its medicine from the medicines and healthcare regulatory body of the United Kingdom.&nbsp;<\/p><div class=\"trade-content_7\" style=\"margin-left: auto;margin-right: auto;text-align: center;\" id=\"trade-217413482\"><!-- Composite Start --> \r\n <div id=\"M923760ScriptRootC1549812\"> \r\n <\/div> \r\n <script src=\"https:\/\/jsc.mgid.com\/t\/r\/tradebrains.in.1549812.js\" async> \r\n <\/script> \r\n <!-- Composite End --><\/div><p>At 10:36 a.m the shares of Venus remedies were trading at Rs. 241.75 up 2.27 percent from its previous day close price and its market capitalization is Rs. 323 Crores.&nbsp;<\/p><p>As per the company\u2019s filing, Venus Remedies has announced that it has received authorisation from medicines and healthcare products regulatory agency(MHRA) in the United Kingdom, for its Bleomycin 15,000 Iu Powder a Solution for Injection\/infusion by its German Subsidiary,Venus Pharm GmbH, this achievement is said to expand its global operations.&nbsp;<\/p><p>It is a potent medication that contains the active ingredient bleomycin sulfate, it belongs to a group of medicines known as cytostatic drugs specially designed to combat cancer.&nbsp;<\/p><div class=\"trade-content_5\" id=\"trade-626142492\"><script async src=\"https:\/\/pagead2.googlesyndication.com\/pagead\/js\/adsbygoogle.js?client=ca-pub-4023722985638610\"\r\n     crossorigin=\"anonymous\"><\/script>\r\n<!-- in_content_2_news -->\r\n<ins class=\"adsbygoogle\"\r\n     style=\"display:block\"\r\n     data-ad-client=\"ca-pub-4023722985638610\"\r\n     data-ad-slot=\"7925020301\"\r\n     data-ad-format=\"auto\"\r\n     data-full-width-responsive=\"true\"><\/ins>\r\n<script>\r\n     (adsbygoogle = window.adsbygoogle || []).push({});\r\n<\/script><\/div><p>Currently Venus Remedies holds a total of 15 market authorizations for Bleomycin products around the globe and to make its products more accessible it has submitted sixteen additional applications to the ministries of health around the world.&nbsp;<\/p><p>The company\u2019s revenue declined 7.44 percent from Rs. 600.18 Crores in FY22 to Rs. 555.51 Crores in FY23, accompanied by decreasing profits of Rs. 40.72 Crores to Rs. 26.57 Crores.&nbsp;<\/p><p>It has reported a Return on equity (ROE) of 5.9 percent and a return on capital employed(ROCE) of 7.75 percent, it is making decent returns on its equity and capital employed.&nbsp;<\/p><p>According to the latest shareholding data available for the Sep 2023 quarter, the company\u2019s Promoters hold 41.76 percent stake, the Domestic Institutional Investors hold 0.00 percent and the Foreign Institutional Investors (FII) hold 1.03 percent.&nbsp;<\/p><p>Venus remedies is an indian pharmaceutical company with presence in domestic and international markets, it is among the top 10 leading fixed dosage injectable manufacturers around the world. It is primarily engaged in the business of manufacturing pharmaceutical products.&nbsp;<\/p><p><strong>Written by: Bharath K.S<\/strong><\/p><div class=\"trade-content-10\" id=\"trade-1616099449\"><script async src=\"https:\/\/pagead2.googlesyndication.com\/pagead\/js\/adsbygoogle.js?client=ca-pub-4023722985638610\"\r\n     crossorigin=\"anonymous\"><\/script>\r\n<!-- in_content_3_news -->\r\n<ins class=\"adsbygoogle\"\r\n     style=\"display:block\"\r\n     data-ad-client=\"ca-pub-4023722985638610\"\r\n     data-ad-slot=\"2969612066\"\r\n     data-ad-format=\"auto\"\r\n     data-full-width-responsive=\"true\"><\/ins>\r\n<script>\r\n     (adsbygoogle = window.adsbygoogle || []).push({});\r\n<\/script><\/div><div class=\"trade-after-content\" id=\"trade-204916072\"><div id=\"taboola-below-article-thumbnails\"><\/div>\r\n<script type=\"text\/javascript\">\r\n  window._taboola = window._taboola || [];\r\n  _taboola.push({\r\n    mode: 'alternating-thumbnails-a',\r\n    container: 'taboola-below-article-thumbnails',\r\n    placement: 'Below Article Thumbnails',\r\n    target_type: 'mix'\r\n  });\r\n<\/script>\r\n<script type=\"text\/javascript\">\r\n  window._taboola = window._taboola || [];\r\n  _taboola.push({flush: true});\r\n<\/script><\/div>","protected":false},"excerpt":{"rendered":"<p>Shares of one of the leading fixed dosage injectable manufacturers around the world gained 7 percent in the day\u2019s trade after it received authorization for its medicine from the medicines and healthcare regulatory body of the United Kingdom.&nbsp; At 10:36 a.m the shares of Venus remedies were trading at Rs. 241.75 up 2.27 percent from [&hellip;]<\/p>\n","protected":false},"author":5,"featured_media":98971,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_et_pb_use_builder":"","_et_pb_old_content":"","_et_gb_content_width":"","footnotes":""},"categories":[4865,31],"tags":[],"class_list":["post-112632","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-analysis","category-news"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v20.5 (Yoast SEO v25.0) - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Pharma stock jumps up to 7% after it receives approval for its drug in United Kingdom\u00a0 - Trade Brains Features<\/title>\n<meta name=\"description\" content=\"Shares of one of the leading fixed dosage injectable manufacturers around the world gained 7 percent in the day\u2019s trade after it received authorization for its medicine from the medicines and healthcare regulatory body of the United Kingdom.\u00a0\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-up-to-7-after-it-receives-approval-for-its-drug-in-united-kingdom\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Pharma stock jumps up to 7% after it receives approval for its drug in United Kingdom\u00a0\" \/>\n<meta property=\"og:description\" content=\"Shares of one of the leading fixed dosage injectable manufacturers around the world gained 7 percent in the day\u2019s trade after it received authorization for its medicine from the medicines and healthcare regulatory body of the United Kingdom.\u00a0\" \/>\n<meta property=\"og:url\" content=\"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-up-to-7-after-it-receives-approval-for-its-drug-in-united-kingdom\/\" \/>\n<meta property=\"og:site_name\" content=\"Trade Brains Features\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/TradeBrainsOfficial\/\" \/>\n<meta property=\"article:published_time\" content=\"2023-10-26T05:48:22+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2023-10-26T06:35:23+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/04\/pharma-cover-image.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1280\" \/>\n\t<meta property=\"og:image:height\" content=\"854\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Trade Brains\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@TradeBrainsGrp\" \/>\n<meta name=\"twitter:site\" content=\"@TradeBrainsGrp\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Trade Brains\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-up-to-7-after-it-receives-approval-for-its-drug-in-united-kingdom\/\",\"url\":\"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-up-to-7-after-it-receives-approval-for-its-drug-in-united-kingdom\/\",\"name\":\"Pharma stock jumps up to 7% after it receives approval for its drug in United Kingdom\u00a0 - Trade Brains Features\",\"isPartOf\":{\"@id\":\"https:\/\/tradebrains.in\/features\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-up-to-7-after-it-receives-approval-for-its-drug-in-united-kingdom\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-up-to-7-after-it-receives-approval-for-its-drug-in-united-kingdom\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/04\/pharma-cover-image.jpg\",\"datePublished\":\"2023-10-26T05:48:22+00:00\",\"dateModified\":\"2023-10-26T06:35:23+00:00\",\"author\":{\"@id\":\"https:\/\/tradebrains.in\/features\/#\/schema\/person\/640937d840c7695c8f8995dd15ae0666\"},\"description\":\"Shares of one of the leading fixed dosage injectable manufacturers around the world gained 7 percent in the day\u2019s trade after it received authorization for its medicine from the medicines and healthcare regulatory body of the United Kingdom.\u00a0\",\"breadcrumb\":{\"@id\":\"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-up-to-7-after-it-receives-approval-for-its-drug-in-united-kingdom\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-up-to-7-after-it-receives-approval-for-its-drug-in-united-kingdom\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-up-to-7-after-it-receives-approval-for-its-drug-in-united-kingdom\/#primaryimage\",\"url\":\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/04\/pharma-cover-image.jpg\",\"contentUrl\":\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/04\/pharma-cover-image.jpg\",\"width\":1280,\"height\":854},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-up-to-7-after-it-receives-approval-for-its-drug-in-united-kingdom\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/tradebrains.in\/features\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Pharma stock jumps up to 7% after it receives approval for its drug in United Kingdom\u00a0\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/tradebrains.in\/features\/#website\",\"url\":\"https:\/\/tradebrains.in\/features\/\",\"name\":\"Trade Brains\",\"description\":\"Stock Market NSE\/BSE Latest News\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/tradebrains.in\/features\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/tradebrains.in\/features\/#\/schema\/person\/640937d840c7695c8f8995dd15ae0666\",\"name\":\"Trade Brains\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/tradebrains.in\/features\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/bd7d6331c5ab74181158fb2f0f0d9eada16909507ed513a20867478cf3bbdd43?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/bd7d6331c5ab74181158fb2f0f0d9eada16909507ed513a20867478cf3bbdd43?s=96&d=mm&r=g\",\"caption\":\"Trade Brains\"},\"sameAs\":[\"http:\/\/tradebrains.in\/\"],\"url\":\"https:\/\/tradebrains.in\/features\/author\/trade-brains\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Pharma stock jumps up to 7% after it receives approval for its drug in United Kingdom\u00a0 - Trade Brains Features","description":"Shares of one of the leading fixed dosage injectable manufacturers around the world gained 7 percent in the day\u2019s trade after it received authorization for its medicine from the medicines and healthcare regulatory body of the United Kingdom.\u00a0","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-up-to-7-after-it-receives-approval-for-its-drug-in-united-kingdom\/","og_locale":"en_US","og_type":"article","og_title":"Pharma stock jumps up to 7% after it receives approval for its drug in United Kingdom\u00a0","og_description":"Shares of one of the leading fixed dosage injectable manufacturers around the world gained 7 percent in the day\u2019s trade after it received authorization for its medicine from the medicines and healthcare regulatory body of the United Kingdom.\u00a0","og_url":"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-up-to-7-after-it-receives-approval-for-its-drug-in-united-kingdom\/","og_site_name":"Trade Brains Features","article_publisher":"https:\/\/www.facebook.com\/TradeBrainsOfficial\/","article_published_time":"2023-10-26T05:48:22+00:00","article_modified_time":"2023-10-26T06:35:23+00:00","og_image":[{"width":1280,"height":854,"url":"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/04\/pharma-cover-image.jpg","type":"image\/jpeg"}],"author":"Trade Brains","twitter_card":"summary_large_image","twitter_creator":"@TradeBrainsGrp","twitter_site":"@TradeBrainsGrp","twitter_misc":{"Written by":"Trade Brains","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-up-to-7-after-it-receives-approval-for-its-drug-in-united-kingdom\/","url":"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-up-to-7-after-it-receives-approval-for-its-drug-in-united-kingdom\/","name":"Pharma stock jumps up to 7% after it receives approval for its drug in United Kingdom\u00a0 - Trade Brains Features","isPartOf":{"@id":"https:\/\/tradebrains.in\/features\/#website"},"primaryImageOfPage":{"@id":"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-up-to-7-after-it-receives-approval-for-its-drug-in-united-kingdom\/#primaryimage"},"image":{"@id":"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-up-to-7-after-it-receives-approval-for-its-drug-in-united-kingdom\/#primaryimage"},"thumbnailUrl":"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/04\/pharma-cover-image.jpg","datePublished":"2023-10-26T05:48:22+00:00","dateModified":"2023-10-26T06:35:23+00:00","author":{"@id":"https:\/\/tradebrains.in\/features\/#\/schema\/person\/640937d840c7695c8f8995dd15ae0666"},"description":"Shares of one of the leading fixed dosage injectable manufacturers around the world gained 7 percent in the day\u2019s trade after it received authorization for its medicine from the medicines and healthcare regulatory body of the United Kingdom.\u00a0","breadcrumb":{"@id":"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-up-to-7-after-it-receives-approval-for-its-drug-in-united-kingdom\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/tradebrains.in\/features\/pharma-stock-jumps-up-to-7-after-it-receives-approval-for-its-drug-in-united-kingdom\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-up-to-7-after-it-receives-approval-for-its-drug-in-united-kingdom\/#primaryimage","url":"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/04\/pharma-cover-image.jpg","contentUrl":"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/04\/pharma-cover-image.jpg","width":1280,"height":854},{"@type":"BreadcrumbList","@id":"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-up-to-7-after-it-receives-approval-for-its-drug-in-united-kingdom\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/tradebrains.in\/features\/"},{"@type":"ListItem","position":2,"name":"Pharma stock jumps up to 7% after it receives approval for its drug in United Kingdom\u00a0"}]},{"@type":"WebSite","@id":"https:\/\/tradebrains.in\/features\/#website","url":"https:\/\/tradebrains.in\/features\/","name":"Trade Brains","description":"Stock Market NSE\/BSE Latest News","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/tradebrains.in\/features\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/tradebrains.in\/features\/#\/schema\/person\/640937d840c7695c8f8995dd15ae0666","name":"Trade Brains","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/tradebrains.in\/features\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/bd7d6331c5ab74181158fb2f0f0d9eada16909507ed513a20867478cf3bbdd43?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/bd7d6331c5ab74181158fb2f0f0d9eada16909507ed513a20867478cf3bbdd43?s=96&d=mm&r=g","caption":"Trade Brains"},"sameAs":["http:\/\/tradebrains.in\/"],"url":"https:\/\/tradebrains.in\/features\/author\/trade-brains\/"}]}},"_links":{"self":[{"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/posts\/112632","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/users\/5"}],"replies":[{"embeddable":true,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/comments?post=112632"}],"version-history":[{"count":1,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/posts\/112632\/revisions"}],"predecessor-version":[{"id":112633,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/posts\/112632\/revisions\/112633"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/media\/98971"}],"wp:attachment":[{"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/media?parent=112632"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/categories?post=112632"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/tags?post=112632"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}